R. Paul Robertson MD

R. Paul Robertson, M.D. is a Professor of Medicine at the University of Minnesota and a Professor of Medicine and Pharmacology at the University of Washington. He is also President Emeritus of the Pacific Northwest Diabetes Research Institute.  He received most of his post-graduate training at the University of Washington where he rose to the rank of Professor of Medicine and Pharmacology in 1980 and was appointed Division Head in Clinical Pharmacology. In 1983 he was appointed Professor of Medicine and Vice-Chair of the Department at the University of Colorado.  In 1986 he was appointed Professor of Medicine and Cell Biology at the University of Minnesota where was the first recipient of the endowed Pennock Chair in Diabetes Research, Director of the General Clinical Research Center, and Head, Division of Diabetes, Endocrinology, and Nutrition.   He returned to Seattle in to become President/CEO/Scientific Director of the Pacific Northwest Diabetes Research Institute from 1997-2009.  He has been elected into membership of the American Society for Clinical Investigation and the Association of American Physicians.  He was the 2009 President for Medicine and Science of the American Diabetes Association, Editor-in-Chief (1986-1990) of Diabetes, a member of the Editorial Board (2000-2009) of the Journal of Biological Chemistry, Editor-in-Chief (2006-1010) of Endocrine Reviews , andEditor in Chief (2009-2013) of Translations in Endocrinology and Metabolism.  He is the incoming Editor-in-Chief for the Journal of Clinical Endocrinology and Metabolism beginning January, 2015. Honors include the endowed Pennock Chair for Diabetes Research at the University of Minnesota; Banting and Best Lecturer at the University of Toronto; Moses Barron Award of the Minnesota Affiliate of the American Diabetes Association; the Albert Renold Award of the American Diabetes Association, and the Banting Medal for Service of the American Diabetes Association.  Dr. Robertson has published over 350 manuscripts with primary emphasis on pancreatic islet function in humans, animals and clonal cell lines.  His most recent research activities are centered on studies of glucose toxicity and oxidative stress of the beta cell as seen in type 2 diabetic patients  and metabolic consequences of pancreas and islet transplantation in patients with type 1 diabetes mellitus.